Researchers have identified a previously unknown mechanism that helps breast cancer cells spread to other parts of the body, a process known as metastasis. The discovery, reported by a team of scientists, reveals a specific molecular pathway that cancer cells use to break away from the primary tumor and travel through the bloodstream. This finding could open the door to new treatments that block metastasis, the leading cause of death in breast cancer patients.

Key takeaways

  • A newly discovered mechanism explains how breast cancer cells become mobile and invade other tissues.
  • The process involves a specific protein that acts as a switch, turning on genes that promote cell movement.
  • Blocking this protein in laboratory models reduced the spread of cancer cells.
  • The finding may lead to new therapies that target metastasis directly.
  • Further research is needed to confirm if these results apply to human patients.

How breast cancer cells become mobile

Metastasis occurs when cancer cells gain the ability to leave the original tumor, enter the bloodstream or lymphatic system, and form new tumors in distant organs. For decades, scientists have tried to understand exactly how this happens. The new study, according to the original report from Medical Xpress, describes a mechanism that involves a protein called NEDD9. This protein appears to act as a master regulator, turning on a set of genes that allow cancer cells to change shape and move.

When NEDD9 is active, it triggers a cascade of signals that make the cells more invasive. The researchers found that breast cancer cells with high levels of NEDD9 were much more likely to spread in laboratory experiments. In contrast, when they reduced the activity of NEDD9, the cells lost their ability to migrate.

The role of the tumor microenvironment

The study also highlights the importance of the tumor microenvironment, the surrounding tissue that supports cancer growth. According to the source report, the researchers discovered that signals from the microenvironment can activate NEDD9 in cancer cells. This means that the environment around the tumor plays a direct role in driving metastasis. Understanding this interaction could help doctors identify patients at higher risk of cancer spread.

Potential for new treatments

The discovery of this mechanism offers a promising target for drug development. If scientists can create a drug that blocks NEDD9 or the signals that activate it, they might be able to stop breast cancer from spreading. The original report notes that the researchers are now working to find compounds that can inhibit this pathway. However, it is important to note that these findings are still at an early stage. Much more research, including clinical trials in humans, will be needed before any new treatment becomes available.

What this means for patients

For people with breast cancer, the idea of a treatment that prevents metastasis is very appealing. Metastatic breast cancer is much harder to treat and has a poorer outlook than early stage disease. If this research leads to a new drug, it could be used alongside existing treatments to reduce the risk of recurrence. For now, the best way to prevent metastasis is still early detection and standard therapies such as surgery, radiation, and chemotherapy.

Frequently Asked Questions

What is the new mechanism behind breast cancer metastasis?

The newly discovered mechanism involves a protein called NEDD9 that acts as a master switch. When activated, it turns on genes that allow breast cancer cells to change shape, move, and invade other tissues. This process is a key step in metastasis.

How was this mechanism discovered?

Researchers used laboratory models of breast cancer to study how cells become mobile. They identified NEDD9 by analyzing which genes were turned on in invasive cells. They then tested what happened when they blocked this protein, which reduced the cells ability to spread.

Could this lead to a new treatment for breast cancer?

It is possible. The finding provides a clear target for drug development. However, any new treatment would need to go through many years of testing to make sure it is safe and effective in humans. The research is still in its early stages.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.